Generation of MAGE-C2/CT10-specific T cell clones for immunotherapy of multiple myeloma

被引：0
|
作者：
Spoeck, Stefanie [1 ]
Reinhard, Henrike [1 ]
Meyer, Sabrina [1 ]
Luetkens, Tim [1 ]
Cao, Yanran [1 ]
Berdien, Belinda [1 ]
Eiermann, Thomas [1 ]
Bokemeyer, Carsten [1 ]
Sezer, Orhan [1 ]
Fehse, Boris [1 ]
Atanackovic, Djordje [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy
    de Carvalho, Fabricio
    Alves, Veruska L. F.
    Braga, Walter M. T.
    Xavier, Celso V., Jr.
    Colleoni, Gisele W. B.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) : 191 - 195
  • [2] MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy
    Fabricio de Carvalho
    Veruska L. F. Alves
    Walter M. T. Braga
    Celso V. Xavier
    Gisele W. B. Colleoni
    Cancer Immunology, Immunotherapy, 2013, 62 : 191 - 195
  • [3] Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma
    Pabst, Caroline
    Zustin, Jozef
    Jacobsen, Frank
    Luetkens, Tim
    Kroeger, Nicolaus
    Schilling, Georgia
    Bokemeyer, Carsten
    Sauter, Guido
    Atanackovic, Djordje
    Marx, Andreas
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 89 (02) : 175 - 181
  • [4] Cancer/Testis Antigens MAGE-C1/CT7 and MAGE-C2/CT10 Are Expressed in 90% of Multiple Myeloma Samples and Can Be Explored in Combined Immunotherapy for This Malignancy
    de Carvalho, Fabricio
    Lia, Veruska
    Alves, Fook
    Moises, Walter
    Braga, Tobias
    Xavier, Celso Vieira, Jr.
    Braga Colleoni, Gisele Wally
    BLOOD, 2012, 120 (21)
  • [5] Cancer-testis Antigen MAGE-C2/CT10 Promotes Proliferation and Resistance to Apoptosis in Multiple Myeloma
    Lajmi, N.
    Luetkens, T.
    Cao, Y.
    Hildebrandt, Y.
    Bartels, K.
    Bokemeyer, C.
    Kroeger, N.
    Atanackovic, D.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S101 - S101
  • [6] Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients
    Reinhard, H.
    Yousef, S.
    Luetkens, T.
    Fehse, B.
    Berdien, B.
    Kroeger, N.
    Atanackovic, D.
    BLOOD CANCER JOURNAL, 2014, 4 : e212 - e212
  • [7] Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients
    H Reinhard
    S Yousef
    T Luetkens
    B Fehse
    B Berdien
    N Kröger
    D Atanackovic
    Blood Cancer Journal, 2014, 4 : e212 - e212
  • [8] Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
    Curioni-Fontecedro, A.
    Pitocco, R.
    Schoenewolf, N. L.
    Holzmann, D.
    Soldini, D.
    Dummer, R.
    Calvieri, S.
    Moch, H.
    Mihic-Probst, D.
    Fitsche, A.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [9] Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients
    Curioni-Fontecedro, Alessandra
    Nuber, Natko
    Mihic-Probst, Daniela
    Seifert, Burkhardt
    Soldini, Davide
    Dummer, Reinhard
    Knuth, Alexander
    van den Broek, Maries
    Moch, Holger
    PLOS ONE, 2011, 6 (06):
  • [10] CANCER-TESTIS ANTIGEN MAGE-C2/CT10 PROMOTES PROLIFERATION AND ENHANCES RESISTANCE TO DNA DAMAGE MEDIATED APOPTOSIS IN MULTIPLE.MYELOMA
    Lajmi, Nesrine
    Luetkens, Tim
    Cao, Yanran
    Hildebrandt, York
    Bartels, Katrin
    Templin, Julia
    Spock, Stefanie
    Yousef, Sara
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordie
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S139 - S139
12345